An experimental Alzheimer’s drug modestly slowed the brain disease’s inevitable worsening — but the anxiously awaited new data leaves unclear how much difference that might make in people’s lives.
…
I spend far too long on Instagram nowadays. So long, in fact, that I have favourites, one of whom I am not afraid to confess to (the rest are mostly women golfers): Scott Evan Davis. He describes…
The availability of COVID-19 vaccines earlier this year allowed for the partial reboot of life as usual during the pandemic. But the omicron variant — and its delta predecessor — have come along to…
My personal journey with Alzheimer’s began in 2005 when my wife, Valerie, received her diagnosis with this terrible disease, one that robs the afflicted of their minds and forces family and friends…
In a wide-ranging interview with Al Majalla, Michael Mainelli discusses Saudi-UK ties, investments in AI and renewable energy and describes Saudi Vision 2030 as 'amazing and ambitious'
Intended as a means of avoiding future deadly conflagrations, nations' refusal to impose sanctions and targeted countries' ability to circumvent them made them ineffective in many cases
After a devastating fire in 2019, this 1,000-year-old symbol of French pride and identity is nearing its reopening, yet few know its connection to Syria's Qalb Lozeh and Middle Eastern architecture